Back to mobile site
Get it on Google Play

Intelligent Bio Solutions files FDA 510(k) for fingerprint drug screening

September 9, 2026 8:30 AM EDT Send to a Friend
Intelligent Bio Solutions Inc. (Nasdaq: INBS) has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration, seeking ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login